Investigation of BDNF gene expression level by analysis of dysregulation of miRNA-15a: An in-silico approach
Abstract: Type 2 Diabetic retinopath (T2DR) remains the leading cause of vision loss and preventable blindness in adults aged 20–74 years, particularly in middle-income and high-income countries. The pathogenesis of T2DR is a predominant cause of visual impairment and a range of hyperglycemia linked pathways have been implicated in the initiation and progression of this condition. Apparently in the past T2DR was solely considered a vascular disease as opposed to the present time where it is recognised as a neuro-vascular disease. Some pro-survival neurotrophins such as brain derived neurotrophic factor (BDNF) are considered to guard retinal ganglion and amacrine cells from degenerative. Significant reduction in the levels of BDNF have been witnessed in diabetic patients as well as animal models. miRNAs are a group of 21-23 nucleotide long, highly conserved sequences of endogenous RNAs that do not encode for any protein. Researches carried out over the last decade gives plenty of proof about the miR-15a importance in T2DR. Henceforth, miR15a could be used for the experimental purposes. miRNAs can be considered as an efficient biomarker as they maintain their stability and utility over rigorous processing phases and the presence of quantitative detection boosts their therapeutical significance. Keywords: Type 2 Diabetic Retinopathy, Neurodegeneration, BDNF, Prognosis, Biomarker, miR-15a, Bioinformatics